$28.25
-0.20-0.7%
al cierre: Nov 17, 4:00 PM EST
$28.25
N/A
After hour: 4:00 PM EST

The average analyst price target for Parabilis Medicines is $40.80, 44.4% above the current price. Of 5 analysts, 5 rate it Buy. Targets range from $39 to $45. The latest change came on Nov 9, 2026, when Canaccord Genuity initiated coverage of Parabilis Medicines with a Buy rating and a $39 price target.
Price Target Range — 2 Quarters
Analyst Consensus — 5 Analysts
Rating Trend — Last 9 Months